You are here:
Refine Your Search
Records 1 to
6
of 6 records published between 05/25/2014 and 05/25/2019 from author Ingrid Druwe
2019
Druwe, I., J. Davis, J. Gift, I. Cote, AND J. Lee. Building an Adverse Outcome Pathway Network for Arsenic-Induced DIseases-Poster. Society of Toxicology, Baltimore, MD, March 10 - 14, 2019.
Vulimiri, Suryanarayana, M. Angrish, P. Schlosser, D. Kapraun, J. Melia, K. Zaccaria, I. Druwe, AND E. Yost. Systematic Review and Literature Mapping of Naphthalene Adverse Health Outcomes. 58th Annual Meeting of the Society of Toxicology, Baltimore, Maryland, March 10 - 14, 2019.
2018
Cote, I., J. Vandenberg, I. Druwe, AND M. Angrish. Incorporating Epigenetics Into a Risk Assessment Framework. Chapter 4-3, Toxicoepigenetics. Academic Press Incorporated, Orlando, FL, , 289-310, (2019). https://doi.org/10.1016/B978-0-12-812433-8.00013-7
2017
Druwe, I. AND Allen Davis. Identification of Hotspots of Genetic Risk for Type 2 Diabetes Using GIS Methods. GEMS Annual mtg, Durham, NC, November 07, 2017.
2016
Druwe, I., T. Freudenrich, K. Wallace, Tim Shafer, AND W. Mundy. Comparison of Human Induced Pluripotent Stem Cell-Derived Neurons and Rat Primary CorticalNeurons as In Vitro Models of Neurite Outgrowth. Applied In Vitro Toxicology. Mary Ann Liebert, Inc., Larchmont, NY, 2(1):26-36, (2016).
2015
Druwe, I., T. Freudenrich, K. Wallace, Tim Shafer, AND W. Mundy. Sensitivity of neuroprogenitor cells to chemical-induced apoptosis using a multiplexed assay suitable for high-throughput screening*. TOXICOLOGY. Elsevier Science Ltd, New York, NY, 333:14-24, (2015).